Welcure Drugs & Pharmaceuticals Limited Stock

Equities

WELCURE6

INE331C01017

Pharmaceuticals

Delayed Bombay S.E. 00:45:00 2024-05-03 EDT 5-day change 1st Jan Change
4.57 INR +2.93% Intraday chart for Welcure Drugs & Pharmaceuticals Limited -5.77% +18.70%

Financials

Sales 2022 1.05M 12.6K 17.21K Sales 2023 - Capitalization 54.32M 652K 890K
Net income 2022 - 0 0 Net income 2023 1M 12K 16.39K EV / Sales 2022 125 x
Net cash position 2022 660K 7.92K 10.82K Net cash position 2023 12.16K 145.87 199.33 EV / Sales 2023 -
P/E ratio 2022
502 x
P/E ratio 2023
53.1 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 83.96%
More Fundamentals * Assessed data
Dynamic Chart
Welcure Drugs & Pharmaceuticals Limited Announces the Resignation of Priti Rajesh Kharwar as Additional Director, Effective from March 28, 2024 CI
Welcure Drugs & Pharmaceuticals Appoints Managing Director, CFO MT
Welcure Drugs & Pharmaceuticals Limited Announces Board Resignations CI
Welcure Drugs & Pharmaceuticals Limited Announces Resignation of Vishal Mehra as Chief Financial Officer CI
Welcure Drugs & Pharmaceuticals Limited Announces Resignation of Mr. Vishal Mehra as Managing Director CI
Welcure Drugs & Pharmaceuticals Limited Approves Executive Changes CI
Welcure Drugs & Pharmaceuticals Limited Approves Appointment of Altaf Hussain Shah as Managing Director CI
Welcure Drugs & Pharmaceuticals Limited Approves Appointment of Altaf Hussain Shah as Chief Financial Officer CI
Welcure Drugs & Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Welcure Drugs & Pharmaceuticals Limited Approves the Shifting of the Registered Office CI
Welcure Drugs & Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Welcure Drugs & Pharmaceuticals Limited Announces Change of Address CI
Welcure Drugs & Pharmaceuticals Limited Approves Board Changes CI
Welcure Drugs & Pharmaceuticals Limited Announces Resignation of Mayank Bhandari as Non Executive and Independent Director CI
Welcure Drugs & Pharmaceuticals Limited Announces Executive Changes CI
More news
1 day+2.93%
1 week-5.77%
Current month+21.54%
1 month+15.99%
3 months-2.56%
6 months+16.58%
Current year+18.70%
More quotes
1 week
4.40
Extreme 4.4
5.00
1 month
3.90
Extreme 3.9
5.00
Current year
3.76
Extreme 3.76
5.48
1 year
3.20
Extreme 3.2
5.48
3 years
2.14
Extreme 2.14
12.08
5 years
0.36
Extreme 0.36
12.08
10 years
0.36
Extreme 0.36
12.08
More quotes
Managers TitleAgeSince
Compliance Officer - 22-10-21
Comptroller/Controller/Auditor - 23-09-03
Members of the board TitleAgeSince
Director/Board Member 58 -
Director/Board Member - 23-10-10
Director/Board Member - 23-10-10
More insiders
Date Price Change Volume
24-05-03 4.57 +2.93% 344
24-05-02 4.44 +0.91% 13,397
24-04-30 4.4 -4.97% 20,336
24-04-29 4.63 -4.93% 27,300
24-04-26 4.87 0.00% 19,384

Delayed Quote Bombay S.E., May 03, 2024 at 12:45 am

More quotes
Welcure Drugs and Pharmaceuticals Limited is an India-based company. The Company is engaged in providing services for procurements of order.
More about the company
  1. Stock Market
  2. Equities
  3. WELCURE6 Stock